{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:06:42Z","timestamp":1790856402561,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,2,29]],"date-time":"2012-02-29T00:00:00Z","timestamp":1330473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s13277-012-0356-9","type":"journal-article","created":{"date-parts":[[2012,2,28]],"date-time":"2012-02-28T11:41:16Z","timestamp":1330429276000},"page":"1141-1149","source":"Crossref","is-referenced-by-count":63,"title":["Serum HE4 as a diagnostic and prognostic marker for lung cancer"],"prefix":"10.1007","volume":"33","author":[{"given":"Kota","family":"Iwahori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Hirashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Naka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,29]]},"reference":[{"key":"356_CR1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277\u2013300.","journal-title":"CA Cancer J Clin"},{"key":"356_CR2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.lungcan.2011.02.020","volume":"72","author":"M Fruh","year":"2011","unstructured":"Fruh M. The search for improved systemic therapy of non-small cell lung cancer\u2014what are today\u2019s options? Lung Cancer. 2011;72:265\u201370.","journal-title":"Lung Cancer"},{"key":"356_CR3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0003-4975(98)90007-8","volume":"45","author":"N Martini","year":"1988","unstructured":"Martini N, Kris MG, Gralla RJ, Bains MS, McCormack PM, Kaiser LR, Burt ME, Zaman MB. The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (n2 m0). Ann Thorac Surg. 1988;45:370\u20139.","journal-title":"Ann Thorac Surg"},{"key":"356_CR4","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/1097-0142(19860401)57:7<1318::AID-CNCR2820570711>3.0.CO;2-2","volume":"57","author":"T Shinkai","year":"1986","unstructured":"Shinkai T, Saijo N, Tominaga K, Eguchi K, Shimizu E, Sasaki Y, Fujita J, Futami H, Ohkura H, Suemasu K. Serial plasma carcinoembryonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapy. Cancer. 1986;57:1318\u201323.","journal-title":"Cancer"},{"key":"356_CR5","first-page":"61","volume":"53","author":"JL Pujol","year":"1993","unstructured":"Pujol JL, Grenier J, Daures JP, Daver A, Pujol H, Michel FB. Serum fragment of cytokeratin subunit 19 measured by cyfra 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res. 1993;53:61\u20136.","journal-title":"Cancer Res"},{"key":"356_CR6","first-page":"2136","volume":"54","author":"Y Miyake","year":"1994","unstructured":"Miyake Y, Kodama T, Yamaguchi K. Pro-gastrin-releasing peptide(31-98) is a specific tumor marker in patients with small cell lung carcinoma. Cancer Res. 1994;54:2136\u201340.","journal-title":"Cancer Res"},{"key":"356_CR7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1095\/biolreprod45.2.350","volume":"45","author":"C Kirchhoff","year":"1991","unstructured":"Kirchhoff C, Habben I, Ivell R, Krull N. A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. Biol Reprod. 1991;45:350\u20137.","journal-title":"Biol Reprod"},{"key":"356_CR8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1530\/ror.0.0030086","volume":"3","author":"C Kirchhoff","year":"1998","unstructured":"Kirchhoff C. Molecular characterization of epididymal proteins. Rev Reprod. 1998;3:86\u201395.","journal-title":"Rev Reprod"},{"key":"356_CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-1119(99)00035-9","volume":"229","author":"K Wang","year":"1999","unstructured":"Wang K, Gan L, Jeffery E, Gayle M, Gown AM, Skelly M, Nelson PS, Ng WV, Schummer M, Hood L, Mulligan J. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene. 1999;229:101\u20138.","journal-title":"Gene"},{"key":"356_CR10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0378-1119(99)00342-X","volume":"238","author":"M Schummer","year":"1999","unstructured":"Schummer M, Ng WV, Bumgarner RE, Nelson PS, Schummer B, Bednarski DW, Hassell L, Baldwin RL, Karlan BY, Hood L. Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas. Gene. 1999;238:375\u201385.","journal-title":"Gene"},{"key":"356_CR11","first-page":"6281","volume":"60","author":"CD Hough","year":"2000","unstructured":"Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenshein NB, Cho KR, Riggins GJ, Morin PJ. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res. 2000;60:6281\u20137.","journal-title":"Cancer Res"},{"key":"356_CR12","first-page":"5007","volume":"60","author":"K Ono","year":"2000","unstructured":"Ono K, Tanaka T, Tsunoda T, Kitahara O, Kihara C, Okamoto A, Ochiai K, Takagi T, Nakamura Y. Identification by cDNA microarray of genes involved in ovarian carcinogenesis. Cancer Res. 2000;60:5007\u201311.","journal-title":"Cancer Res"},{"key":"356_CR13","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1073\/pnas.98.3.1176","volume":"98","author":"JB Welsh","year":"2001","unstructured":"Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ, Lockhart DJ, Burger RA, Hampton GM. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci U S A. 2001;98:1176\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"356_CR14","first-page":"5895","volume":"61","author":"V Shridhar","year":"2001","unstructured":"Shridhar V, Lee J, Pandita A, Iturria S, Avula R, Staub J, Morrissey M, Calhoun E, Sen A, Kalli K, Keeney G, Roche P, Cliby W, Lu K, Schmandt R, Mills GB, Bast Jr RC, James CD, Couch FJ, Hartmann LC, Lillie J, Smith DI. Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res. 2001;61:5895\u2013904.","journal-title":"Cancer Res"},{"key":"356_CR15","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1091\/mbc.E03-05-0279","volume":"14","author":"ME Schaner","year":"2003","unstructured":"Schaner ME, Ross DT, Ciaravino G, Sorlie T, Troyanskaya O, Diehn M, Wang YC, Duran GE, Sikic TL, Caldeira S, Skomedal H, Tu IP, Hernandez-Boussard T, Johnson SW, O\u2019Dwyer PJ, Fero MJ, Kristensen GB, Borresen-Dale AL, Hastie T, Tibshirani R, van de Rijn M, Teng NN, Longacre TA, Botstein D, Brown PO, Sikic BI. Gene expression patterns in ovarian carcinomas. Mol Biol Cell. 2003;14:4376\u201386.","journal-title":"Mol Biol Cell"},{"key":"356_CR16","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1158\/1078-0432.CCR-03-0409","volume":"10","author":"KH Lu","year":"2004","unstructured":"Lu KH, Patterson AP, Wang L, Marquez RT, Atkinson EN, Baggerly KA, Ramoth LR, Rosen DG, Liu J, Hellstrom I, Smith D, Hartmann L, Fishman D, Berchuck A, Schmandt R, Whitaker R, Gershenson DM, Mills GB, Bast Jr RC. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res. 2004;10:3291\u2013300.","journal-title":"Clin Cancer Res"},{"key":"356_CR17","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","volume":"65","author":"R Drapkin","year":"2005","unstructured":"Drapkin R, von Horsten HH, Lin Y, Mok SC, Crum CP, Welch WR, Hecht JL. Human epididymis protein 4 (he4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res. 2005;65:2162\u20139.","journal-title":"Cancer Res"},{"key":"356_CR18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ygyno.2005.06.040","volume":"99","author":"DG Rosen","year":"2005","unstructured":"Rosen DG, Wang L, Atkinson JN, Yu Y, Lu KH, Diamandis EP, Hellstrom I, Mok SC, Liu J, Bast Jr RC. Potential markers that complement expression of ca125 in epithelial ovarian cancer. Gynecol Oncol. 2005;99:267\u201377.","journal-title":"Gynecol Oncol"},{"key":"356_CR19","first-page":"3695","volume":"63","author":"I Hellstrom","year":"2003","unstructured":"Hellstrom I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, Drescher C, Urban N, Hellstrom KE. The he4 (wfdc2) protein is a biomarker for ovarian carcinoma. Cancer Res. 2003;63:3695\u2013700.","journal-title":"Cancer Res"},{"key":"356_CR20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1465-9921-7-61","volume":"7","author":"L Bingle","year":"2006","unstructured":"Bingle L, Cross SS, High AS, Wallace WA, Rassl D, Yuan G, Hellstrom I, Campos MA, Bingle CD. Wfdc2 (he4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung. Respir Res. 2006;7:61.","journal-title":"Respir Res"},{"key":"356_CR21","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","volume":"19","author":"MT Galgano","year":"2006","unstructured":"Galgano MT, Hampton GM, Frierson Jr HF. Comprehensive analysis of he4 expression in normal and malignant human tissues. Mod Pathol. 2006;19:847\u201353.","journal-title":"Mod Pathol"},{"key":"356_CR22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1586\/erm.09.39","volume":"9","author":"J Li","year":"2009","unstructured":"Li J, Dowdy S, Tipton T, Podratz K, Lu WG, Xie X, Jiang SW. He4 as a biomarker for ovarian and endometrial cancer management. Expert Rev Mol Diagn. 2009;9:555\u201366.","journal-title":"Expert Rev Mol Diagn"},{"key":"356_CR23","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1373\/clinchem.2010.157073","volume":"57","author":"JM Escudero","year":"2011","unstructured":"Escudero JM, Auge JM, Filella X, Torne A, Pahisa J, Molina R. Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases. Clin Chem. 2011;57:1534\u201344.","journal-title":"Clin Chem"},{"key":"356_CR24","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/IGC.0b013e31821e052e","volume":"21","author":"KD Steffensen","year":"2011","unstructured":"Steffensen KD, Waldstrom M, Brandslund I, Jakobsen A. Prognostic impact of prechemotherapy serum levels of her2, ca125, and he4 in ovarian cancer patients. Int J Gynecol Canc. 2011;21:1040\u20137.","journal-title":"Int J Gynecol Canc"},{"key":"356_CR25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s13277-010-0118-5","volume":"32","author":"S Yamashita","year":"2011","unstructured":"Yamashita S, Tokuishi K, Hashimoto T, Moroga T, Kamei M, Ono K, Miyawaki M, Takeno S, Chujo M, Yamamoto S, Kawahara K. Prognostic significance of he4 expression in pulmonary adenocarcinoma. Tumour Biol. 2011;32:265\u201371.","journal-title":"Tumour Biol"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-012-0356-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-012-0356-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-012-0356-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T17:11:26Z","timestamp":1561396286000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-012-0356-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,29]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["356"],"URL":"https:\/\/doi.org\/10.1007\/s13277-012-0356-9","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,29]]}}}